Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 5Not yet recruiting 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 15Thoracic 1Head & Neck 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 370Head and Neck Neoplasms 356Nasopharyngeal Carcinoma 140Thyroid Neoplasms 124Carcinoma, Non-Small-Cell Lung 93Mouth Neoplasms 84Melanoma 76Breast Neoplasms 75Oropharyngeal Neoplasms 72Colorectal Neoplasms 68Uterine Cervical Neoplasms 66Lung Neoplasms 66Neoplasms 63Ovarian Neoplasms 61Neoplasm Metastasis 52Prostatic Neoplasms 51Stomach Neoplasms 49Pancreatic Neoplasms 47Carcinoma, Squamous Cell 45Triple Negative Breast Neoplasms 43Laryngeal Neoplasms 42Esophageal Neoplasms 42Endometrial Neoplasms 42Thyroid Nodule 37Carcinoma, Renal Cell 37Urinary Bladder Neoplasms 36Sarcoma 34Recurrence 31Carcinoma 30Nasopharyngeal Neoplasms 28

Interventions

Surgical Procedures, Operative 1Specimen Handling 1Pafolacianine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Pelvic Neoplasms × Head & Neck × Clear all
NCT06915727 2026-04-01

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

Mayo Clinic

Phase 3 Recruiting
20 enrolled
GynecologicHead & Neck

Head and Neck Neoplasms, Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡